It was reported that a patient died coincident with peritoneal dialysis therapy.The cause of death was reported as cardiac failure and cardiac arrest.At the time of the event, the patient was at home and was transported to the emergency room.It was not reported what treatment was rendered for the event and the patient passed away.Therapy remained ongoing prior to death; however, it was unknown if the patient was performing therapy before being transported to the emergency room.An autopsy was not performed and the death certificate was not available.No additional information is available at this time.
|
(b)(4).The returned device was evaluated by the product analysis laboratory (pal).The event history log review showed no keystrokes, programming, or use related events that indicated and/or contributed to the reported issue.A service history review revealed no indication that the parts replaced during servicing caused or contributed to the reported event.Visual inspection did not identify any abnormalities that could have contributed to the reported condition.The homechoice device received a returned instrument testing evaluation (rite).This evaluation included functional and electrical testing of the device.The device was determined to meet functional and electrical performance specification requirements per rite testing.Per pal evaluation, there was no failure, malfunction or iipv (increased intraperitoneal volume) events identified that could have caused or contributed to the reported issue of patient passing away.The cause is undetermined.Should additional relevant information become available, a supplemental report will be submitted.
|